You are here » Home » Companies » Company Overview » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE LIVE 15:40 | 21 Feb 948.85 5.55
(0.59%)
OPEN

929.20

HIGH

954.00

LOW

919.90

NSE LIVE 15:55 | 21 Feb 950.00 9.35
(0.99%)
OPEN

925.00

HIGH

955.00

LOW

917.00

OPEN 929.20
PREVIOUS CLOSE 943.30
VOLUME 25394
52-Week high 993.00
52-Week low 715.80
P/E 11.65
Mkt Cap.(Rs cr) 26776.55
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 929.20
CLOSE 943.30
VOLUME 25394
52-Week high 993.00
52-Week low 715.80
P/E 11.65
Mkt Cap.(Rs cr) 26776.55
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   26,777
EPS - TTM () [*S] 81.43
P/E Ratio (X) [*S] 11.65
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 03 Aug 2016
Dividend Yield (%) 0.21
Book Value / Share () [*S] 296.57
P/B Ratio () [*S] 3.20
[*C] Consolidated     [*S] Standalone

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Dec 2016 Dec 2015 % Chg
Net Sales 2535.01 1778.29 42.55
Other Income 14.57 2.14 580.84
Total Income 2549.58 1780.43 43.2
Total Expenses 1769.98 1407.7 25.74
Operating Profit 779.59 372.73 109.16
Net Profit 477.1 196.13 143.26
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Cadila Health. 439.90 -1.02 45032.56
Aurobindo Pharma 685.90 2.44 40138.87
Piramal Enterp. 1898.50 0.36 32758.62
Glenmark Pharma. 948.85 0.59 26776.55
Alkem Lab 1991.40 -2.34 23807.19
Glaxosmit Pharma 2683.40 0.08 22728.40
Biocon 1132.25 0.65 22645.00
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.49
Banks/FIs 3.35
FIIs 34.38
Insurance 0.00
Mutual Funds 3.48
Indian Public 8.40
Custodians 0.00
Other 3.87
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
20/12 IDBI Capital Accumulate 941 PDF IconDetails
22/07 Prabhudas Lilladher Buy 865 PDF IconDetails
15/05 Prabhudas Lilladher Buy 869 PDF IconDetails
13/05 Motilal Oswal Neutral 869 PDF IconDetails
29/01 Prabhudas Lilladher Buy 771 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 0.32% 0.45% 1.49% 1.31%
1 Month 6.64% 6.85% 6.39% 6.69%
3 Month 7.41% 7.38% 11.63% 12.34%
6 Month 9.93% 9.79% 2.44% 2.78%
1 Year 27.06% 26.98% 21.31% 23.54%
3 Year 77.50% 77.67% 38.94% 44.71%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 919.90
954.00
Week Low/High 913.80
955.00
Month Low/High 863.00
973.00
YEAR Low/High 715.80
993.00
All TIME Low/High 1.89
1262.00